FIELD: medicine.
SUBSTANCE: invention relates to medicine and relates to a method for inhibiting growth of tumor cells involving the use of a non-viral genetic construct with including a transmembrane form of a klotho gene, where the tumor cells are transfected with a mixture of genetic constructs including genes of both the transmembrane form Klotho and the secreted form Klotho, transfection is performed in a serum-free medium followed by using the neomycin antibiotic for selecting transfected cells according to neomycin resistance.
EFFECT: invention provides higher inhibition effect of genetic correction.
1 cl, 6 dwg, 4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR THERAPY OF SKIN DAMAGES AND BIOTRANSPLANT THEREFOR | 2014 |
|
RU2588835C1 |
| METHOD OF TREATMENT OF ATOPIC DERMATITIS | 2022 |
|
RU2804005C1 |
| METHOD OF TREATING CORONARY INSUFFICIENCY IN SIMULATED MYOCARDIAL ISCHEMIA | 2010 |
|
RU2444378C1 |
| GENE THERAPY PREPARATION FCU1-BSFM/PP FOR TREATING SOLID TUMOURS | 2023 |
|
RU2824977C1 |
| METHOD OF TREATING CORONARY INSUFFICIENCY | 2014 |
|
RU2572798C1 |
| CELL LINE HUFSHIK RELEASING RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE | 2012 |
|
RU2502798C2 |
| RECOMBINANT PLASMID DNA pcDNA4-Apo-2NLS2 CARRYING SYNTHETIC GENE OF APOPTIN PROTEIN INDUCING p53-INDEPENDENT PROGRAMMED TUMOUR CELL DEATH | 2013 |
|
RU2541777C1 |
| METHOD FOR LOCALLY SUPPRESSING ANGIOGENESIS IN TARGET TISSUE | 2005 |
|
RU2292395C1 |
| RECOMBINANT EL1 PEPTIDE HAVING CYTOTOXIC ACTIVITY RELATIVE TO HUMAN CANCER CELLS | 2017 |
|
RU2683221C1 |
| MEAN FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS TO CELLS OF MAMMALS | 2014 |
|
RU2572575C1 |
